Neurocrine Biosciences, Inc. <NBIX.O>: Deutsche Bank cuts target price to $165 from $190
NBIX•Related News
Rezolve Ai cites U.S. patent 12,412,310 for AI image watermarking technology
RZLV•
Phinia announces availability of 2025 sustainability report
PHIN•
Pipeline co Delek Logistics slides on $200 mln equity offering
DKL•
PAVmed subsidiary Lucid Diagnostics posts 2Q revenue of USD 1.5 million
LUCD•
Maitong Sunshine Q3 FY26 net loss narrows 10% to $37,684; revenue drops 100% to no revenue
MGSD•